MALAT1 and prostate carcinoma: The intratumoral injection of lncRNA-MALAT1 siRNA, which silences lncRNA-MALAT1, could retard the growth and reduce the metastasis of prostate cancer transplant tumors in desmoplastic, nude male mice, thereby prolonging the survival time of tumor-bearing mice [52].